Gastrointestinal (GI) tumors (cancers of the esophagus, gastric, liver, pancreas, colon, and
rectum) contribute to a large number of deaths worldwide. STAT3 is an oncogenic …

Cancer, a prevalent and complex disease, presents a significant challenge to the medical
community. It is characterized by irregular cell differentiation, excessive proliferation …

Extracellular vesicles (EVs) are increasingly used as delivery vehicles for drugs and
bioactive molecules, which usually require intravascular administration. The endothelial …

MicroRNAs (miRNA) are small non-coding RNAs that are 20–23 nucleotides in length,
functioning as regulators of oncogenes or tumor suppressor genes. They are molecular …

Despite decades of research, glioblastoma (GBM) remains invariably fatal among all forms
of cancers. The high level of inter‐and intratumoral heterogeneity along with its biological …

Background: The concentration and duration of intracellular drugs have always been the key
factors for determining the efficacy of the treatment. Efflux of chemotherapeutic drugs or …

Background Glioblastoma multiforme (GBM) is one of the most fatal tumors of the central
nervous system with high rate of disease progression, diagnosis, prognosis and low survival …

The intricate cross-talks between tumor cells and their microenvironment play a key role in
cancer progression and resistance to treatment. In recent years, targeting pro-tumorigenic …

Glioblastoma (GBM) is the most common primary central nervous system tumor and one of
the most lethal cancers worldwide, with morbidity of 5.26 per 100,000 population per year …

Glioblastoma (GB) is the most aggressive form of brain cancer in adults, characterized by
poor survival rates and lack of effective therapies. MicroRNAs (miRNAs) are small, non …